Literature DB >> 32747956

A polycyclic aromatic hydrocarbon-enriched environmental chemical mixture enhances AhR, antiapoptotic signaling and a proliferative phenotype in breast cancer cells.

Larisa M Gearhart-Serna1,2,3, John B Davis4, Mohit Kumar Jolly5, Nishad Jayasundara3,6, Scott J Sauer1, Richard T Di Giulio3, Gayathri R Devi1,2,7.   

Abstract

Emerging evidence suggests the role of environmental chemicals, in particular endocrine-disrupting chemicals (EDCs), in progression of breast cancer and treatment resistance, which can impact survival outcomes. However, most research tends to focus on tumor etiology and the effect of single chemicals, offering little insight into the effects of realistic complex mixture exposures on tumor progression. Herein, we investigated the effect of a polycyclic aromatic hydrocarbon (PAH)-enriched EDC mixture in a panel of normal and breast cancer cells and in a tumor organoid model. Cells or organoids in culture were treated with EDC mixture at doses estimated from US adult intake of the top four PAH compounds within the mixture from the National Health and Nutrition Examination Survey database. We demonstrate that low-dose PAH mixture (6, 30 and 300 nM) increased aryl hydrocarbon receptor (AhR) expression and CYP activity in estrogen receptor (ER) positive but not normal mammary or ER-negative breast cancer cells, and that upregulated AhR signaling corresponded with increased cell proliferation and expression of antiapoptotic and antioxidant proteins XIAP and SOD1. We employed a mathematical model to validate PAH-mediated increases in AhR and XIAP expression in the MCF-7 ER-positive cell line. Furthermore, the PAH mixture caused significant growth increases in ER-negative breast cancer cell derived 3D tumor organoids, providing further evidence for the role of a natural-derived PAH mixture in enhancing a tumor proliferative phenotype. Together, our integrated cell signaling, computational and phenotype analysis reveals the underlying mechanisms of EDC mixtures in breast cancer progression and survival.
© The Author(s) 2020. Published by Oxford University Press. All rights reserved. For Permissions, please email: journals.permissions@oup.com.

Entities:  

Mesh:

Substances:

Year:  2020        PMID: 32747956      PMCID: PMC7791619          DOI: 10.1093/carcin/bgaa047

Source DB:  PubMed          Journal:  Carcinogenesis        ISSN: 0143-3334            Impact factor:   4.944


  68 in total

1.  Methylated polycyclic aromatic hydrocarbons and/or their metabolites are important contributors to the overall estrogenic activity of polycyclic aromatic hydrocarbon-contaminated soils.

Authors:  Monika M Lam; Magnus Engwall; Michael S Denison; Maria Larsson
Journal:  Environ Toxicol Chem       Date:  2017-11-06       Impact factor: 3.742

Review 2.  Endocrine-disrupting compounds and mammary gland development: early exposure and later life consequences.

Authors:  Suzanne E Fenton
Journal:  Endocrinology       Date:  2006-05-11       Impact factor: 4.736

Review 3.  Environmental causes of cancer: endocrine disruptors as carcinogens.

Authors:  Ana M Soto; Carlos Sonnenschein
Journal:  Nat Rev Endocrinol       Date:  2010-05-25       Impact factor: 43.330

Review 4.  Urinary 1-hydroxypyrene and other PAH metabolites as biomarkers of exposure to environmental PAH in air particulate matter.

Authors:  P Strickland; D Kang
Journal:  Toxicol Lett       Date:  1999-09-05       Impact factor: 4.372

5.  3-Methylcholanthrene and other aryl hydrocarbon receptor agonists directly activate estrogen receptor alpha.

Authors:  Maen Abdelrahim; Eric Ariazi; Kyounghyun Kim; Shaheen Khan; Rola Barhoumi; Robert Burghardt; Shengxi Liu; Denise Hill; Richard Finnell; Bogdan Wlodarczyk; V Craig Jordan; Stephen Safe
Journal:  Cancer Res       Date:  2006-02-15       Impact factor: 12.701

6.  Urinary PAH metabolites as biomarkers of exposure in aquatic environments.

Authors:  Gilberto Fillmann; Giles M Watson; Mike Howsam; Eleine Francioni; Michael H Depledge; James W Readman
Journal:  Environ Sci Technol       Date:  2004-05-01       Impact factor: 9.028

Review 7.  An overview of prognostic factors for long-term survivors of breast cancer.

Authors:  Isabelle Soerjomataram; Marieke W J Louwman; Jacques G Ribot; Jan A Roukema; Jan Willem W Coebergh
Journal:  Breast Cancer Res Treat       Date:  2007-03-22       Impact factor: 4.872

Review 8.  Cancer and developmental exposure to endocrine disruptors.

Authors:  Linda S Birnbaum; Suzanne E Fenton
Journal:  Environ Health Perspect       Date:  2003-04       Impact factor: 9.031

9.  Assessing Cancer Risk Associated with Aquatic Polycyclic Aromatic Hydrocarbon Pollution Reveals Dietary Routes of Exposure and Vulnerable Populations.

Authors:  Larisa M Gearhart-Serna; Nishad Jayasundara; Moises Tacam; Richard Di Giulio; Gayathri R Devi
Journal:  J Environ Public Health       Date:  2018-09-19

10.  Microscale In Vitro Assays for the Investigation of Neutral Red Retention and Ethoxyresorufin-O-Deethylase of Biofuels and Fossil Fuels.

Authors:  Sebastian Heger; Kerstin Bluhm; Julia Brendt; Philipp Mayer; Nico Anders; Andreas Schäffer; Thomas-Benjamin Seiler; Henner Hollert
Journal:  PLoS One       Date:  2016-09-29       Impact factor: 3.240

View more
  3 in total

1.  Adaptive stress response genes associated with breast cancer subtypes and survival outcomes reveal race-related differences.

Authors:  Muthana Al Abo; Larisa Gearhart-Serna; Steven Van Laere; Jennifer A Freedman; Steven R Patierno; Eun-Sil Shelley Hwang; Savitri Krishnamurthy; Kevin P Williams; Gayathri R Devi
Journal:  NPJ Breast Cancer       Date:  2022-06-13

Review 2.  Aryl Hydrocarbon Receptor in Oxidative Stress as a Double Agent and Its Biological and Therapeutic Significance.

Authors:  Alevtina Y Grishanova; Maria L Perepechaeva
Journal:  Int J Mol Sci       Date:  2022-06-16       Impact factor: 6.208

3.  Polycyclic Aromatic Hydrocarbons and Mammary Cancer Risk: Does Obesity Matter too?

Authors:  Lydia Lichtiger; Janelle Rivera; Debashish Sahay; Rachel L Miller
Journal:  J Cancer Immunol (Wilmington)       Date:  2021
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.